Bioprospecting of Xylia xylocarpa and its phytoconstituents

Abstract

Bioprospecting is the exploration, extraction and screening of biological diversity and indigenous knowledge for commercially valuable genetic and biochemical resources and also for potential use as pharmaceutical agents. This will probably lead to many new disease-fighting drugs, and leads to substantial profits for the pharma company. The research area of drug design and discovery is at a crossroads. Xylia xylocarpa or Mimosa xylocarpa (Mimosaceae) is a medium sized deciduous tree is selected for research study. As good anti-oxidant activity and good source of polyphenols, flavonoids and saponins, this study was promoted as part of screening new source of natural inhibitors of tyrosinase and 5-lipoxygenase activities and phytochemical composition with major marker compounds through bio-guided fractionation studies. This write-up provides schematic procedure for any natural product which shows potent pharmacological activity that can be used as alternative medicine. All compounds discussed in this report are presented here for the first time from this plant.